Lung Adenocarcinoma — Trials

Lung Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

231 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 27
Ph III recruiting: 6
Growth YoY: —
Industry share: 13%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (28)

clinicaltrialsPublishedShowing 51–54 of 54 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01482585	Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy	unknown	—	200	Samsung Medical CenterOTHER	1	Nov 30, 2011	clinicaltrials
NCT01249053	Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma	unknown	—	100	China Medical University HospitalOTHER	1	Nov 29, 2010	clinicaltrials